Literature DB >> 2986852

Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon.

D Aderka, D Novick, T Hahn, D G Fischer, D Wallach.   

Abstract

The cytotoxic effect of lymphotoxin (LT) and its modulation by interferon (IFN) was quantitatively assessed in uninfected and vesicular stomatitis virus (VSV)-infected cultured cells. Preparations of human LT, which were depleted of IFN, had a significant cytotoxic effect on VSV-infected HeLa, SV-80, WISH, and Vero cells. IFN, most notably IFN-gamma, further potentiated destruction of the infected cells by these LT preparations, when applied on the cells at sub-antiviral IFN concentrations. In contrast, no cytotoxic effect could be observed in any of the examined cells, when applying LT, IFN, or their combination, in the absence of viral infection. Infected cells in which VSV replication was suppressed by treatment with antiviral concentrations of IFN also resisted destruction by LT. These findings indicate that LT cytotoxicity can be selectively directed against virus-infected cells and that IFN can augment this cell-killing mechanism when failing to exert an antiviral effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986852     DOI: 10.1016/0008-8749(85)90003-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  13 in total

1.  Lipopolysaccharide synergizes with tumour necrosis factor-alpha in cytotoxicity assays.

Authors:  H Pfister; T Hennet; T W Jungi
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

2.  Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation.

Authors:  G H Wong; T McHugh; R Weber; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Immunological aspects of the prevention of viral diseases. WHO Workshop.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  Reversion of the antichlamydial effect of tumor necrosis factor by tryptophan and antibodies to beta interferon.

Authors:  Y Shemer-Avni; D Wallach; I Sarov
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.

Authors:  J Klefstrom; E Arighi; T Littlewood; M Jäättelä; E Saksela; G I Evan; K Alitalo
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

6.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.

Authors:  Y Endo; T Kikuchi; M Nakamura
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

8.  Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection.

Authors:  G I Byrne; B Grubbs; T J Marshall; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.

Authors:  Y Shemer-Avni; D Wallach; I Sarov
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.

Authors:  J Tufariello; S Cho; M S Horwitz
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.